Skip to content
Screener

Upstream Bio, Inc. UPB Other Income (Expense)

Other Income (Expense) at other companies

Amgen logo
AmgenAMGN
-$73M+81.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$234.3M-46.7%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$2.73M-8.3%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$1M+74.7%
Savara logo
SavaraSVRA
$737K-29.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$18.21M-55.0%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$394.54M-55.9%
Enterprise value$316.1M-62.8%
P/S124.9×-204×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense):
Interest income2,6594,4315,7139,174
Other income (expense), net7(50)(23)(50)
Total other income, net2,6664,3815,6909,124
Net loss$(39,702)$(39,966)$(80,293)$(67,236)
Net loss per share attributable to common stockholders, basic and diluted$(0.73)$(0.74)$(1.47)$(1.25)
Weighted-average common shares outstanding, basic and diluted54,567,97653,770,86854,450,79853,694,424
Comprehensive loss:

Item 1. Financial Statements.

FAQ

What is Upstream Bio, Inc.'s other income (expense)?
Upstream Bio, Inc. (UPB) reported other income (expense) of $2.67M in Q2 2026.
How has Upstream Bio, Inc.'s other income (expense) changed year-over-year?
Upstream Bio, Inc.'s other income (expense) decreased by 39.1% year-over-year, from $4.38M to $2.67M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Upstream Bio, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude